TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions (Q28271369)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions
scientific article

    Statements

    TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions (English)
    0 references
    0 references
    Pradeep B J Reddy
    0 references
    Taylor H Schreiber
    0 references
    Naveen K Rajasagi
    0 references
    Amol Suryawanshi
    0 references
    Sachin Mulik
    0 references
    Toshiro Niki
    0 references
    Mitsuomi Hirashima
    0 references
    Eckhard R Podack
    0 references
    Barry T Rouse
    0 references
    October 2012
    0 references
    86
    0 references
    19
    0 references
    10606-20
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit